BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Diagnosis
10 results:

  • 1. Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
    Al-Toubat M; Serrano S; Elshafei A; Koul K; Feibus AH; Balaji KC
    Urol Oncol; 2023 Nov; 41(11):455.e7-455.e15. PubMed ID: 37838503
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Somatic and Germline Variants Affect Prognosis and Susceptibility in prostate cancer.
    Rocca C; Rocca G; Zampieri P; Dell'atti L; Bianchi N; Ippolito C; Aguiari G
    Anticancer Res; 2023 Jul; 43(7):2941-2949. PubMed ID: 37351993
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.
    Ragavi R; Muthukumaran P; Nandagopal S; Ahirwar DK; Tomo S; Misra S; Guerriero G; Shukla KK
    Urol Oncol; 2023 Aug; 41(8):340-353. PubMed ID: 37032230
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differences in prostate cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable cancer Risk Factors, and Clinical Factors.
    Stopsack KH; Nandakumar S; Arora K; Nguyen B; Vasselman SE; Nweji B; McBride SM; Morris MJ; Rathkopf DE; Slovin SF; Danila DC; Autio KA; Scher HI; Mucci LA; Solit DB; Gönen M; Chen Y; Berger MF; Schultz N; Abida W; Kantoff PW
    Clin Cancer Res; 2022 Jan; 28(2):318-326. PubMed ID: 34667026
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.
    Goel S; Bhatia V; Kundu S; Biswas T; Carskadon S; Gupta N; Asim M; Morrissey C; Palanisamy N; Ateeq B
    Nat Commun; 2021 Sep; 12(1):5325. PubMed ID: 34493733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metabolic deregulation in prostate cancer.
    Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
    Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. prostate cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to prostate cancer.
    Jung SH; Shin S; Kim MS; Baek IP; Lee JY; Lee SH; Kim TM; Lee SH; Chung YJ
    Eur Urol; 2016 May; 69(5):823-30. PubMed ID: 26542946
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Elevated levels of foxa1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-level expression of forkhead-box protein A1 in metastatic prostate cancer.
    Jain RK; Mehta RJ; Nakshatri H; Idrees MT; Badve SS
    Histopathology; 2011 Apr; 58(5):766-72. PubMed ID: 21401706
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.